应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AUPH Aurinia Pharmaceuticals Inc
休市中 04-26 16:00:00 EDT
4.91
+0.04
+0.82%
盘后
4.90
-0.01
-0.20%
19:43 EDT
最高
5.01
最低
4.86
成交量
98.55万
今开
4.89
昨收
4.87
日振幅
3.08%
总市值
7.10亿
流通市值
6.47亿
总股本
1.45亿
成交额
486.06万
换手率
0.75%
流通股本
1.32亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
暂无数据
公司概况
公司名称:
Aurinia Pharmaceuticals Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Aurinia Pharmaceuticals Inc.是根据《商业公司法》组建的(加拿大阿尔伯塔省)。Aurinia制药是一家完全整合的生物制药公司,专注于提供治疗目标患者群体的疗法,这些患者群体受到自身免疫、肾脏和罕见病的影响,医疗需求未得到满足。2021年1月,Aurinia制药推出了首个获得FDA批准的口服药物LUPKYNIS(voclosporin),用于治疗活动性LN成人患者。LUPKYNIS是一种口服CNI免疫抑制剂,当与霉酚酸酯(MMF)(尽管MMF目前尚未被批准)和类固醇联合使用时,已被证明可以改善LN的近期和长期结果。通过抑制钙调神经磷酸酶,LUPKYNIS降低细胞因子活化,阻断白细胞介素IL-2表达和T细胞介导的免疫反应。LUPKYNIS还可能稳定足细胞,从而防止蛋白尿。
发行价格:
--
{"stockData":{"symbol":"AUPH","market":"US","secType":"STK","nameCN":"Aurinia Pharmaceuticals Inc","latestPrice":4.91,"timestamp":1714161600000,"preClose":4.87,"halted":0,"volume":985501,"hourTrading":{"tag":"盘后","latestPrice":4.9001,"preClose":4.91,"latestTime":"19:43 EDT","volume":18821,"amount":92415.84,"timestamp":1714175017632},"delay":0,"floatShares":131743093,"shares":144617762,"eps":-0.544695,"marketStatus":"休市中","marketStatusCode":7,"change":0.04,"latestTime":"04-26 16:00:00 EDT","open":4.89,"high":5.01,"low":4.86,"amount":4860564.3518245,"amplitude":0.030801,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.544695,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714377600000},"adr":0,"listingDate":951454800000,"adjPreClose":4.87,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":4.87,"preClose":4.87,"latestTime":"09:24 EDT","volume":3,"amount":14.61,"timestamp":1714137899987},"postHourTrading":{"tag":"盘后","latestPrice":4.9001,"preClose":4.91,"latestTime":"19:43 EDT","volume":18821,"amount":92415.84,"timestamp":1714175017632},"volumeRatio":0.822763724041464},"requestUrl":"/m/hq/s/AUPH","defaultTab":"news","newsList":[],"profile":{"websiteUrl":"http://www.auriniapharma.com","stockEarnings":[{"period":"1week","weight":-0.016},{"period":"1month","weight":-0.018},{"period":"3month","weight":-0.3855},{"period":"6month","weight":-0.3171},{"period":"1year","weight":-0.5585},{"period":"ytd","weight":-0.4538}],"compareEarnings":[{"period":"1week","weight":0.0265},{"period":"1month","weight":-0.0285},{"period":"3month","weight":0.0428},{"period":"6month","weight":0.2376},{"period":"1year","weight":0.2324},{"period":"ytd","weight":0.0693}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aurinia Pharmaceuticals Inc.是根据《商业公司法》组建的(加拿大阿尔伯塔省)。Aurinia制药是一家完全整合的生物制药公司,专注于提供治疗目标患者群体的疗法,这些患者群体受到自身免疫、肾脏和罕见病的影响,医疗需求未得到满足。2021年1月,Aurinia制药推出了首个获得FDA批准的口服药物LUPKYNIS(voclosporin),用于治疗活动性LN成人患者。LUPKYNIS是一种口服CNI免疫抑制剂,当与霉酚酸酯(MMF)(尽管MMF目前尚未被批准)和类固醇联合使用时,已被证明可以改善LN的近期和长期结果。通过抑制钙调神经磷酸酶,LUPKYNIS降低细胞因子活化,阻断白细胞介素IL-2表达和T细胞介导的免疫反应。LUPKYNIS还可能稳定足细胞,从而防止蛋白尿。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.106403},{"month":2,"riseRate":0.5,"avgChangeRate":0.009372},{"month":3,"riseRate":0.4,"avgChangeRate":0.102117},{"month":4,"riseRate":0.5,"avgChangeRate":-0.015681},{"month":5,"riseRate":0.555556,"avgChangeRate":-0.011752},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.039513},{"month":7,"riseRate":0.555556,"avgChangeRate":0.03731},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.068337},{"month":9,"riseRate":0.444444,"avgChangeRate":0.078247},{"month":10,"riseRate":0.6,"avgChangeRate":0.041208},{"month":11,"riseRate":0.5,"avgChangeRate":-0.001599},{"month":12,"riseRate":0.4,"avgChangeRate":0.111111}],"exchange":"NASDAQ","name":"Aurinia Pharmaceuticals Inc","nameEN":"Aurinia Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aurinia Pharmaceuticals Inc(AUPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aurinia Pharmaceuticals Inc(AUPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aurinia Pharmaceuticals Inc,AUPH,Aurinia Pharmaceuticals Inc股票,Aurinia Pharmaceuticals Inc股票老虎,Aurinia Pharmaceuticals Inc股票老虎国际,Aurinia Pharmaceuticals Inc行情,Aurinia Pharmaceuticals Inc股票行情,Aurinia Pharmaceuticals Inc股价,Aurinia Pharmaceuticals Inc股市,Aurinia Pharmaceuticals Inc股票价格,Aurinia Pharmaceuticals Inc股票交易,Aurinia Pharmaceuticals Inc股票购买,Aurinia Pharmaceuticals Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aurinia Pharmaceuticals Inc(AUPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aurinia Pharmaceuticals Inc(AUPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}